Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-03-03 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion · Stock Option −25,000 0
2017-03-02 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion +167,506 $6.34 $1.1M 236,776
2017-03-02 Labrucherie Gil M SVP & Chief Financial Officer Sale −167,506 $15.15 $2.5M 69,270
2017-03-02 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion · Stock Option −167,506 7,494
2017-02-21 Lingnau Lutz Director Exercise or conversion +30,000 $5.14 $154K 60,450
2017-02-21 Lingnau Lutz Director Sale −30,000 $13.08 $392K 30,450
2017-02-21 Lingnau Lutz Director Exercise or conversion · Stock Option −30,000 0
2017-02-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −1,965 $13.14 $26K 55,637
2017-02-16 ROBIN HOWARD W President & CEO Sale −8,636 $13.14 $113K 169,272
2017-02-16 Nicholson John SVP & Chief Operating Officer Sale −3,237 $13.14 $43K 182,089
2017-02-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −2,359 $13.14 $31K 69,270
2017-02-16 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −2,195 $13.14 $29K 63,648
2017-02-16 Gergel Ivan P. SVP & Chief Medical Officer Sale −1,457 $13.14 $19K 45,022
2017-02-16 Doberstein Stephen K SVP & Chief Scientific Officer Sale −1,261 $13.14 $17K 34,504
2017-02-10 Nicholson John SVP & Chief Operating Officer Exercise or conversion +45,000 $4.65 $209K 185,326
2017-02-10 Nicholson John SVP & Chief Operating Officer Exercise or conversion · Employee Stock Option (right to buy) −45,000 0
2017-02-08 ROBIN HOWARD W President & CEO Exercise or conversion +87,500 $4.65 $407K 265,408
2017-02-08 ROBIN HOWARD W President & CEO Sale −87,500 $13.04 $1.1M 177,908
2017-02-08 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −87,500 0
2017-02-03 Nicholson John SVP & Chief Operating Officer Exercise or conversion +8,505 $4.65 $40K 148,831

Page 45 of 55 · 1,088 trades